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Abstract:  
Exercise is a potent physiological stimulus for growth hormone (GH) secretion, and both aerobic 
and resistance exercise result in significant, acute increases in GH secretion. Contrary to 
previous suggestions that exercise-induced GH release requires that a ‘threshold’ intensity be 
attained, recent research from our laboratory has shown that regardless of age or gender, there is 
a linear relationship between the magnitude of the acute increase in GH release and exercise 
intensity. The magnitude of GH release is greater in young women than in young men and is 
reduced by 4–7-fold in older individuals compared with younger individuals. Following the 
increase in GH secretion associated with a bout of aerobic exercise, GH release transiently 
decreases. As a result, 24-hour integrated GH concentrations are not usually elevated by a single 
bout of exercise. However, repeated bouts of aerobic exercise within a 24-hour period result in 
increased 24-hour integrated GH concentrations. 
 
Because the GH response to acute resistance exercise is dependent on the work-rest interval and 
the load and frequency of the resistance exercise used, the ability to equate intensity across 
different resistance exercise protocols is desirable. This has proved to be a difficult task. 
Problems with maintaining patent intravenous catheters have resulted in a lack of studies 
investigating alterations in acute and 24-hour GH pulsatile secretion in response to resistance 
exercise. However, research using varied resistance protocols and sampling techniques has 
reported acute increases in GH release similar to those observed with aerobic exercise.  
 
In young women, chronic aerobic training at an intensity greater than the lactate threshold 
resulted in a 2-fold increase in 24-hour GH release. The time line of adaptation and the 
mechanism(s) by which this training effect occurs are still elusive. Unfortunately, there are few 
studies investigating the effects of chronic resistance training on 24-hour GH release. 
 
The decrease in GH secretion observed in individuals who are older or have obesity is associated 
with many deleterious health effects, although a cause and effect relationship has not been 
established. While exercise interventions may not restore GH secretion to levels observed in 
young, healthy individuals, exercise is a robust stimulus of GH secretion. The combination of 
exercise and administration of oral GH secretagogues may result in greater GH secretion than 
exercise alone in individuals who are older or have obesity. Whether such interventions would 
result in favourable clinical outcomes remains to be established. 
 
Article: 
Growth hormone (GH) is secreted by the anterior pituitary in a pulsatile pattern. GH secretion is 
regulated by two hypothalamic peptides: GHreleasing hormone (GHRH), which stimulates GH 
synthesis and secretion, and somatostatin, which inhibits GH release without affecting GH 
synthesis.
[1,2] 
Many of the metabolic effects of GH are mediated by insulin-like growth factor 
(IGF)-I, which is synthesised in the liver under GH control and exerts a rapid negative feedback 
on GH release. In addition, recent data suggest that a GH secretagogue receptor, expressed in 
somatotroph cells in the anterior pituitary and hypothalamus, may also mediate the stimulation of 
GH secretion via a signal transduction pathway that is distinct from that of GHRH. Both 
synthetic GH-releasing peptides (GHRPs) and endogenous GHRP-like neuropeptides (e.g. 
ghrelin) may activate this receptor and the endogenous GHRP-like neuropeptides may be 
involved in the regulation of GH secretion.
[1-3]
 
 
Human growth hormone (hGH) represents a family of proteins rather than a single hormone and 
over 100 forms of GH have been identified in plasma,
[4]
 with apparently different physiological 
functions.
[5] 
In the circulation, the dominant form of GH is a 22kD protein. However, 
approximately 10% of circulating GH is a 20kD protein and there are also various lower 
molecular weight fragments of GH.
[4] 
All of these may be immunoactive in some GH 
immunoassays. However, in order for GH to be biologically active, it must be able to dimerize 
two GH receptors on the cell surface. This requires that two specific binding regions of the GH 
molecule be present in order to bind to two GH receptors. The proportion of intact GH molecules 
in the circulation varies between 50–95% of immunoactive GH, as measured by polyclonal com-
petitive radioimmunoassays (RIA).
[6] 
Thus, polyclonal RIAs tend to yield serum GH 
concentrations that are higher than many of the assays employing monoclonal antibodies. 
However, the various commercially available monoclonal assays in use today employ different 
antibodies with different specificity for the various molecular forms of GH.
[6,7] 
Thus, the 
measurement of GH concentration using various assay techniques can result in vastly discrepant 
results. Although several bioassay techniques have also been used to assess GH levels
[8-11]
 these 
are not widely available. 
 
The isoforms of GH that are measurable in the circulation may be altered by muscle afferent 
stimulation,
[12] 
acute aerobic
[13]
 and heavy resistance exercise.
[14] 
Some of these changes are 
detected only by bioassay.
[12] 
After fractionation, 71–75% (for pre- and post-exercise samples, 
respectively) of GH was found in the <30 kDa fraction.
[14] 
This review will focus on studies that 
have used immunoassay as the technique for assessing GH concentration, since it is used most 
commonly. The authors recognise that immunoassay procedures have limitations for inference 
about the actual ‘bioavailable’ and ‘functional’ GH that leads to downstream GH signalling in 
target tissues in response to exercise. To this end, the development of immunofunctional assays, 
such as that described by Strasburger et al.
[10] 
or Ikeda et al.,
[11] 
are likely to become more critical 
for assessing the ability of different types of exercise to actually affect changes in the  
downstream signalling pathway of GH, ultimately leading to changes in protein expression. 
 
GH deficiency in adults with hypothalamic or pituitary disease leads to altered body composi-
tion
[15]
 and has been associated with increased risk of premature cardiovascular disease.
[16] 
In 
addition, GH deficiency is linked to reduced exercise capacity,
[17] 
insulin resistance,
[18] 
dyslipidaemia,
[19,20] 
vascular dysfunction
[21]
 and reduced left ventricular mass and lower ejection 
fractions.
[22]
 In GH deficient adults, the beneficial effects of administration of hGH include 
increased lean body mass and decreased fat mass, reduced abdominal/visceral obesity, 
favourable effects on lipoprotein and bone metabolism and improved patient perception of 
quality of life.
[23-27] 
Several studies have reported significant improvements in aerobic exercise 
capacity with GH replacement in adults with GH deficiency.
[28-31]
 These may be the result of 
increased left ventricular mass and cardiac ejection fraction.
[32,33]
 However, the ability of exoge-
nous GH administration to increase muscular strength in GH-deficient adults has been less con-
sistently demonstrated, with some studies reporting improvements
[17,28,34]
 and others reporting 
little or no change.
[35,36] 
For a more complete review of the effects of GH replacement in adults 
with growth hormone deficiency, see Carroll et al.
[37] 
or Simpson et al.
[38]
 
 
GH production and release decreases with age
[39,40]
 by approximately 14% per decade after the 
age of 40 years
[41]
 and is decreased in conditions such as obesity.
[42,43] 
Many age related changes 
in GH secretion resemble those seen in GH-deficient adults including: reduced muscle mass and 
exercise capacity, increased body fat especially abdominal visceral fat, unfavourable lipid and 
lipoprotein profiles, reduction in bone mineral density, and increased risk of vascular disease. 
However, treatment of healthy older adults with GH results in less impressive benefits than is 
observed in adults with GH deficiency due to hypothalamic or pituitary disease. In general, GH 
treatment of older adults results in changes in body composition (increased lean body mass, 
decreased fat mass and decreased abdominal fat) but no improvement in exercise 
performance.
[44-49] 
Data from a recently completed clinical trial at the University of Virginia 
investigating the effects of GH administration with and without exercise training in older adults 
confirm these previous findings.
[50,51]
 
 
Many physiologic factors alter pulsatile GH secretion, including age, gender, body composition, 
sleep, nutrition, exercise and serum concentrations of gonadal steroids, insulin and IGF-I. 
Among these various factors, the amount of abdominal visceral fat is the most important 
predictor of the 24-hour integrated GH concentration.
[52] 
However, this review is limited to the 
effects of exercise on GH release. The reader should consult the review by Hartman
[2]
 for a more 
comprehensive overview of the effects of these other physiological factors on GH release. These 
other factors should be taken into account when reviewing the literature regarding the effects of 
exercise on GH secretion. 
 
Exercise is a potent stimulus of GH release in young adults. Since decreased GH secretion in 
aging and other conditions such as obesity is associated with many detrimental health effects it 
can be suggested that the use of regular exercise as a stimulus for GH release may have positive 
effects on health and well being. Initial studies
[50,53-56]
 evaluating the GH response to exercise 
performed minimal sampling and compared GH concentrations pre- and post-exercise. It is now 
well known that GH secretion from the anterior pituitary is pulsatile and that more frequent 
sampling regimens are necessary to assess the effects of stimuli on GH release. Thus, the 
primary purpose of this paper is to review findings on the effects of acute and chronic aerobic 
and resistance exercise on GH release. In addition, where available, we will discuss the effects of 
exercise on GH pulsatility. 
 
Acute Aerobic Exercise 
Initial studies of the growth hormone response to aerobic exercise reported that GH release 
occurs as a result of exercise with initial elevation of GH observed approximately 15 minutes 
into exercise and peak values attained at or near the end of exercise.
[53-55] 
Recent studies, using 
more frequent sampling techniques to measure the inherent pulsatile pattern of GH release, 
support the contention that aerobic exercise of appropriate intensity and duration is a potent 
physiological stimulus for GH release in young adults.
[57-60] 
The pattern of GH release to acute 
aerobic exercise is depicted in figure 1. 
 
 
 
Women have higher GH concentrations at rest, greater basal GH secretion, greater 24-hour 
integrated area under the concentration-time curve (AUC) and less orderly GH release.
[1,59,61-65] 
Although the general pattern of exercise-induced GH release is similar in men and women,
[53,66] 
more recent studies have demonstrated gender differences in the GH response to exercise.
[59,60] 
Women exhibit an anticipatory response to exercise and a more rapid attainment of peak GH 
concentrations with exercise.
[59,60,67]
 Because these studies employed morning exercise, it is 
possible that these findings are related to the increase in morning ambulatory-induced GH 
release in young women compared with young men.[61] Nevertheless, the response to exercise is 
likely independent of circadian rhythm, as time of day does not influence the GH response to 
exercise in young men.
[68] 
While young women and men both attain large increases in GH 
concentrations during exercise, the increase from baseline is significantly higher for men than 
women,
[60,66] 
even though the absolute change in exercise-induced AUC is similar.
[59]
 
Exercise intensity has been suggested as a key modifier of exercise-induced GH release. It has 
been suggested that a threshold of exercise intensity may be necessary for GH release.
[69-71] 
In 
contrast, recent studies from our laboratory
[58,67]
 indicate that the magnitude of GH release rose 
linearly with increasing intensity of exercise in young men and young women. We also observed 
that the incremental increase in GH release with increasing exercise intensity was greater in 
young women than in young men.
[67] 
This concept is illustrated in figure 2. Using deconvolution 
analysis, this increase was shown to be attributable to an increase in the mass of GH secreted per 
pulse in both genders.
[58,67] 
 
 
 
Although it has been shown that a single, acute aerobic exercise session results in an increase in 
GH release during and immediately following exercise, the effects of acute exercise on 24-hour 
GH release have not been well described. A transient decrease in GH release is observed 
following the increase in GH secretion associated with a bout of aerobic exercise.
[68] 
As a result, 
24-hour integrated GH concentrations are not usually elevated by a single bout of exercise.
[72] 
However, we have shown that three 30-minute bouts of exercise (separated by 1 or 3.5 hours) 
resulted in a 60% increase in 24-hour integrated GH AUC compared with the control day.
[73]
 
Repeated bouts of exercise within 60 minutes of each other did not result in attenuation of 
exercise-induced GH release, suggesting that exercise may ‘break through’ GH auto-negative 
feedback. When the 24-hour time frame was further divided into day and night, the daytime GH 
AUC was increased by approximately 150% compared with rest, whereas the night-time GH 
AUC was not different for exercise or rest.
[73] 
Similarly, Kern et al.
[74] 
observed that mean 
nocturnal GH concentrations, measured every 15 minutes for 8 hours, did not differ after a single 
bout of daytime moderate or intense aerobic exercise, compared with the control condition. 
Recently, Ronsen et al.
[75] 
also reported a more pronounced GH response to a second bout of 
exercise on the same day, although frequent blood sampling was completed only during the 
second exercise session. Thus, while GH concentrations at the end of the second exercise session 
were higher than at the end of the first session, no comparisons of GH AUC or mean GH 
concentration can be made for the two sessions. 
 
Several studies have specifically investigated the influence of time of day on exercise-induced 
GH release.
[68,76-79]
 The exact time of day chosen for exercise varied, but generally comparisons 
of GH release were made between morning, afternoon, evening and nocturnal (usually midnight) 
exercise sessions. GH release
[76-79]
 and GH secretion parameters (as assessed by deconvolution 
analysis)
[68] 
were unaffected by time of day and this observation persisted regardless of the inten-
sity of acute exercise (high, moderate) or the mode of exercise (stair climbing, arm ergometry, 
cycling, treadmill) employed. Kanaley et al.
[68] 
reported that exercise at any time of day resulted 
in an approximately 2-fold increase in GH secretion rate and mass of GH secreted per pulse, with 
no effect on GH half-life. Recently, our laboratory reported that one 30 minute bout of exercise 
as well as three 10 minute bouts of exercise (spread throughout the day) resulted in similar 
increases in 24-hour GH release (approximately 1.4-fold in those without obesity and 
approximately 1.2-fold in those with obesity).
[80] 
Interestingly, Galassetti et al.
[79] 
reported that 
even when plasma glucose levels were controlled with clamping, morning exercise reduced the 
GH, adrenaline (epinephrine), noradrenaline (norepinephrine) and cortisol response to afternoon 
exercise in men. Conversely, morning exercise followed by afternoon exercise in women 
resulted in preservation of or increased response of GH, adrenaline, noradrenaline and 
cortisol.
[79] 
These findings underscore the need to further investigate gender differences in 
exercise- induced GH release. 
 
In contrast to our findings in young adults, when the GH response to exercise intensity was 
examined in older men and women, we found that the GH response to exercise was blunted in 
older individuals.
[81,82] 
In men, the slope values for the relationship between GH release during 
exercise and recovery and exercise intensity was 3.9-fold higher in younger than older men. 
Furthermore, the GH response to exercise in the older men was attenuated until the highest 
exercise intensity was reached.
[81] 
Similarly, exercise-stimulated GH secretion in postmenopausal 
women was 5.7–7.3-fold lower than that attained in exercising premenopausal women.
[82] 
This 
attenuation in exercise stimulated GH release was observed in postmenopausal women both with 
and without oestrogen supplementation, suggesting that aging, independent of estrogen status, 
impairs the GH secretory response.
[82] 
These data suggest that in older individuals exercise may 
need to be used in combination with other provocative stimuli of GH release (i.e. a GH 
secretagogue) to obtain GH levels similar to those observed in young adults. Table I provides a 
summary of studies that have investigated the effects of acute aerobic exercise on GH release. 
 
Other investigators have also reported that older individuals have decreased exercise-induced 
GH release.
[83,84] 
These decrements in exercise- stimulated GH release may be due to excessive 
somatostatin (SRIH) release and/or diminished GHRH secretion
[1]
 or a reduction in the 
endogenous GHRP-like ligand. A recent study by Marcell et al.
[83] 
reported that pyridostigmine, 
which may indirectly suppress SRIH, administered 30 minutes prior to exercise augmented GH 
AUC by 74 and 24% in young men, and by 224 and 59% in older men during maximal and 
submaximal exercise, respectively. While the fractional increase in GH AUC was greater in 
 
older versus younger men, the absolute magnitude of the change was similar, suggesting that 
pyridostigmine was equally effective in both groups at counteracting SRIH inhibition of GH 
release.
[83] 
Gusenoff et al.
[85] 
investigated the interrelationships of cortisol and GH secretory 
dynamics at rest in healthy older men and women. They reported that postmenopausal women 
have reduced cortisol-GH pattern synchrony (increased cross-ApEn score; a measure of coupling 
between two signals over a specified time frame) than men of the same age, even though 
orderliness of GH release was similar in older men and women. Thus, with aging, a deterioration 
of coordinated neuroendocrine function may occur.
[85]
 
 
GH release at rest and during exercise is also reduced in individuals with increased body fat. 
[43,80,86]
 When comparing various pharmacologic and physiologic stimuli, the magnitude of the 
GH response to exercise in individuals with obesity is greater than that observed with levodopa 
or clonidine,
[87,88] 
but similar to that observed with GHRH, pyridostigmine or arginine.
[87,89-92] 
However, the exercise-induced GH response in individuals with obesity is less than that observed 
after stimulation with GHRP or combined secretagogues.
[87,89,91] 
Thus, the same metabolic 
factors that attenuate the GH response to pharmacological stimuli may also inhibit the GH 
response to exercise in individuals with obesity.
[2]
 
 
 Acute Resistance Exercise and Growth Hormone (GH) Release 
Studies of the acute GH response to resistance exercise have been hampered by the difficulty of 
equating intensity levels across individuals and studies, maintaining patent intravenous catheters 
throughout exertion and obtaining blood samples without interfering with resistance exercise. 
Most studies have sampled pre-exercise, at some time intervals during exercise and at varying 
intervals postexercise for up to several hours. Regardless of the sampling intervals or the 
resistance protocol employed, the pattern of GH release is similar. In all cases, the GH 
concentration peaks at or slightly after the termination of exercise and returns to baseline levels 
by 90 minutes postexercise.
[93-102] 
This pattern is similar to that observed for the GH response to 
acute aerobic exercise. 
 
 
Notably, to our knowledge, no reports are available regarding the effects of acute resistance exer-
cise on pulsatile 24-hour GH secretion. Nindl et al.
[99] 
investigated GH pulsatility in young men 
for 12 hours following acute heavy resistance exercise performed in the late afternoon (15.00–
17.00). The pattern of GH release during the 12 hours following exercise is shown in figure 3. 
GH levels were significantly elevated for the 20 minutes immediately after acute heavy 
resistance exercise and then gradually declined over the next 30 minutes, so that by 1 hour 
postexercise, GH concentrations were similar to those observed during the control day.
[99] 
Acute 
heavy resistance exercise influenced the temporal pattern of overnight GH pulsatile release, such 
that GH release was lower in the first half of sleep, but higher in the second half.
[99] 
Additionally, 
this exercise resulted in lower maximal GH values and lower mean peak amplitude, even though 
overall mean GH values were not significantly reduced.
[99]
 
 
 
 
An in-depth study of the GH response to different resistance exercise protocols was completed 
by Kraemer et al.
[94] 
This study investigated six different heavy resistance exercise protocols 
(HREP) and observed sizeable variation in the GH response to the different protocols in young 
men. Generally, resistance exercise protocols with high total work and short rest intervals or high 
repetitions with moderate power (70% or greater), resulted in the greatest GH response. 
[94,102,103]
 
The same HREP were used to examine the acute GH response of young women to resistance 
exercise.
[97]
 In women, shortening the duration of the sets or increasing the rest period between 
sets did not result in significant stimulation of GH release and by 90 minutes postexercise, GH 
concentrations fell below baseline values. The largest GH responses were observed with the 
resistance protocols that minimised rest, were of longer duration and were combined with 
moderately heavy resistance.
[97] 
Similarly, Mulligan et al.
[104] 
found that when women performed 
multiple sets of resistance exercise GH release was greater and more prolonged than with a 
single set of resistance exercise. When Kraemer et al.
[98] 
investigated the effect of menstrual 
cycle phase on resistance exercise-induced GH release, they observed a greater GH response 
during the luteal phase compared with the follicular phase. Further, when GH AUC was 
normalised for fat-free mass and total work done, there was no gender difference in GH release. 
In general, resistance exercise with higher total volume resulted in a greater GH response than 
resistance exercise with lower total volume. 
[94,96,97] 
In contrast, Takarada et al.,
[101]
 reported that 
GH increased approximately 290-fold over resting GH values in response to very low intensity 
resistance exercise (20% 1 repetition maximum [RM]) when vascular occlusion occurred 
simultaneously. This extreme increase in GH may be due to regional accumulation of 
metabolites without considerable tissue damage.
[101]
 
 
Although acute resistance exercise results in increased GH release,
[83,94,96,97,101,103,105-108]
 the GH 
response to resistance exercise is influenced by the work-rest intervals, and the load and 
frequency of the resistance exercise that is used.
[94,102,103]
 Additionally, as observed with aerobic 
exercise- induced GH release, the interindividual response to acute resistance exercise is highly 
variable.
[100] 
These results indicate that comparisons of the GH response to acute resistance 
exercise between studies should be made with extreme caution. In addition, future studies should 
attempt to equalise total work when comparing resistance exercise protocols and should assess 
the effect of resistance exercise on the daily (24-hour) pulsatile release of GH. Comparison of the 
physiological mechanisms involved in the increase of GH after acute aerobic versus acute 
resistance exercise, may also be important as these two training techniques clearly result in 
different phenotypic responses in humans. 
 
Similar to responses observed with acute aerobic exercise, most reports suggest that acute resis-
tance exercise results in increased GH release in elderly men and women.
[83,109,110
] As expected, 
peak GH values and integrated GH AUC were markedly attenuated in older individuals 
compared with younger individuals.
[83,110] 
However, one report
[93]
 did not find increased GH 
release with acute heavy resistance exercise in older men or women. As depicted in figure 4, 
while elderly participants did not respond with increased GH release, young and middle-aged 
men and women had substantial increases in GH release (approximately 200- and 20-fold, 
respectively). This disparity in stimulation of GH release in different age groups may be due to 
methodological differences, particularly, differences in total work done or intensity of exercise. 
Weltman et al.
[81] 
reported that for older men, intensity of aerobic exercise had to reach the 
highest workload before substantial increases in GH were observed. It is possible that the 
workload or intensity must be ‘relatively’ much greater in older individuals (compared with 
younger individuals) in order to achieve substantial increases in GH release with resistance 
exercise. Table II provides a summary of studies that have investigated the effects of acute 
resistance exercise on GH release.  
 
Clearly, acute resistance exercise of appropriate intensity and duration results in increased GH 
release in all age groups. Dependent on the protocol employed, the average peak GH 
concentration attained during acute resistance exercise in young men and women ranges between 
5–25 µg/L.[93-97,99,100,104,108,110,111] Similarly, the average peak GH concentration 
attained during acute aerobic exercise is also between 5–25 µg/L.[58-60,66,67,69,70,83,112-
115] When extremely high intensity aerobic work (90% maximal oxygen uptake [V.O2max]) is 
employed, mean GH concentrations as high as 50 gg/L have been reported.[112] Thus, the 
magnitude of the GH response is similar with either acute aerobic or resistance exercise of  
appropriate intensity and duration. Ideally, a comparison of the GH response to both acute 
 
 
 
aerobic and resistance exercise should be made within the same individuals. To our knowledge, 
no such study exists. 
 
Chronic Endurance Training and GH Release 
Studies have shown that endurance training reduces the exercise-induced GH release in response 
to acute constant load exercise when the absolute workload was unchanged.
[115,116] 
These data 
suggest that the GH response to exercise is influenced to a greater degree by relative exercise 
intensity than by absolute exercise intensity. In young eumenorrhoeic women who participated in 
endurance training for 1 year, a nearly 2-fold increase in spontaneous 24-hour integrated serum 
GH concentrations was observed provided some of the training was at an intensity above the 
lactate threshold (LT).
[117] 
In middle-aged and young competitive cyclists, progressive endurance 
training for 4 months resulted in similar increases for maximal oxygen consumption. However, 
neither the young nor middle-aged participants had an increase in acute exercise-induced GH 
release in response to maximal aerobic exercise on a cycle ergometer.
[84] 
The middle-aged 
cyclists had a much lower GH response to acute maximal exercise than the young cyclists both 
before and after training. It should be noted that no comparisons to sedentary age-matched 
controls were made and the effect of progressive endurance training on spontaneous 24- hour GH 
release was not examined in this study. 
 
Although relatively few studies have prospectively evaluated the effect of exercise training on 
the GH-IGF-I axis in older adults, it appears that GH secretion may be less responsive to 
exercise training. In a study of older men (aged 50–78 years), serum IGF-I concentrations did not 
differ between a group of marathon runners and age- matched sedentary controls.
[118] 
Similarly, a 
sustained programme of moderate-intensity resistance exercise training in elderly individuals for 
1 year failed to increase serum IGF-I levels.
[119] 
We studied the effects of 1 year of exercise 
training (either supervised aerobic training [4 days/wk] or supervised strength training [3 
days/wk]) in healthy older (aged 59–79 years) adults and observed no significant change in 24-
hour integrated GH concentrations.
[50]
 The lack of effect of training on the GH-IGF-I axis in 
these older individuals may have been attributable to: (i) lack of a sufficient training stimulus; 
(ii) lack of change in percentage body fat and abdominal visceral fat (both of which are 
correlated with GH release in older adults); and/or (iii) intrinsic aging of the GH-IGF-I axis. 
 
Chronic Resistance Training and GH Release 
Studies investigating the effect of chronic resistance training on GH release have shown that 
resting levels of GH are unchanged with resistance training.
[56,107,108,119-123] 
Hurley et al.,
[124] 
investigated the effect of 10 weeks of resistance training on resting 24-hour GH release in young 
men and observed a reduced daytime mean GH concentration compared with pre-training. 
Samples were taken hourly but averaged for 24-hour, daytime and night-time means. In this 
study, the investigators did not calculate an integrated GH AUC for the pre-, mid- or post-
training GH concentrations. Marx et al.,
[120] 
measured the resting GH response to low-volume 
circuit training and high-volume periodised resistance training in young women. Both training 
regimens resulted in significant improvements in muscular performance after 12 weeks, but only 
the high-volume periodised resistance training resulted in improvements in strength, power and 
speed after 24-weeks of training. Neither training regimen resulted in changes in resting GH 
levels in young women.
[120] 
This may be due to the fact that only a single GH sample was taken 
pre-training, and after 12 or 24 weeks of training. 
Several studies have reported that the effect of chronic progressive resistance training on the GH 
response to acute resistance exercise is similar pre- and post-training in both men and 
women.
[107,121] 
Craig et al.
[56] 
reported that young men increased GH concentrations 5-fold in 
response to an acute bout of resistance exercise and this increased to approximately 6-fold after 
training. However, Kraemer et al.
[108] 
reported that training resulted in lower GH concentrations 
during late recovery (30 minutes postexercise) in young men, even though the response during 
the acute bout was similar to pre-training. Recently, Kraemer et al.
[111] 
trained participants for 19 
weeks on a lower-body resistance training programme that involved only concentric work or 
both concentric and eccentric work and then detrained them for 4 weeks. The GH response to 
acute concentric and acute eccentric work was measured pre- and post-training and after de-
training. The groups that trained concentrically had a greater GH response to acute concentric 
work compared with acute eccentric work, while the group that trained both concentric and 
eccentric muscle actions had a greater GH response to acute eccentric work. Interestingly, 
detraining resulted in a reduced GH response to acute concentric work in the groups that trained 
concentrically, with no reduction of the GH response to acute eccentric work with detraining. 
However, in the group that trained both concentric and eccentric muscle action, detraining 
resulted in a greater GH response to acute concentric work compared with post-training, while 
the GH response to acute eccentric work was reduced compared with post- training. These 
results indicate that the GH response to acute exercise in men is sensitive to the type of muscle 
action used during training.
[111] 
Here again, the use of a single GH sample for the assessment of 
GH release provides only limited insight due to the pulsatile nature of GH secretion. 
 
Although the American College of Sports Medicine
[125]
 recommends the addition of resistance 
exercise to a programme of regular aerobic training, there are few studies that assess the effect of 
concurrent strength and endurance training on hormone concentrations. A recent study by Bell et 
al.,
[126] 
noted that the resting GH concentration did not change during 12 weeks of either strength 
training alone, endurance training alone or concurrent strength and endurance training, despite 
the fact that changes in strength and max2OV
 were observed. Again, the use of a single sample at 
any timepoint for the assessment of GH release likely confounded the results. No assessment of 
the GH response to either acute aerobic or resistance training was determined pre- or post-
training.
 
Resistance training has become a popular intervention for elderly individuals in an effort to try to 
slow, decrease or even reverse the age-related declines in strength and functional ability that 
occur with aging. Craig et al.,
[56] 
reported that while elderly males had increased GH 
concentrations to an acute bout of resistance exercise, chronic progressive resistance training for 
12 weeks did not increase the response to acute exercise. Similar findings were reported by Pyka 
et al.,
[119] 
after 1 year of resistance training in elderly men. These findings have been 
corroborated by several other newer studies.
[108,109,127]
 We also reported that 1 year of resistance 
training did not result in an increase in 24-hour GH release in older men.
[50] 
It has been 
repeatedly shown that the type of resistance exercise and the total work completed are crucial for 
the exercise-induced increase in GH release to occur. It is possible that the intensity and volume 
of resistance training that is required to produce a training effect in older adults is not a feasible 
workload for them to complete regularly without injury. Further, more complete investigations of 
the 24-hour GH response to resistance exercise and training are needed before conclusions can 
be made about the usefulness of resistance training for elevating GH in elderly individuals. 
Interestingly, several studies showed strength gains in elderly individuals without changes in 
GH,
[108,109,127,128] 
which suggests that factors other than GH (likely neuromuscular adaptations) 
may be important in producing these functional responses in elderly individuals. 
 
Neuroendocrine Control 
The neuroendocrine mechanisms involved in exercise-induced release of GH have not been 
completely elucidated and are complex in nature, although the effect appears to occur via 
hypothalamic input. The mechanism would putatively involve GHRH release and/or 
somatostatin withdrawal and possibly, natural GHRP-like ligand release (e.g. ghrelin) or some 
combination of these mechanisms (figure 5). A complete review of this topic is beyond the scope 
of this review and readers are referred to Giustina and Veldhuis
[1]
 for more in-depth coverage of 
the possible neuroendocrine mechanisms involved in the control of exercise-induced GH release. 
 
 
 
The stimulation of GH secretion by exercise likely involves multiple neuroregulatory responses 
in the GH axis,
[60] 
as well as a variety of peripheral feedback signals. Several neurotransmitters 
have been implicated but the final common pathway likely involves either stimulation of GHRH 
secretion and/or inhibition of somatostatin release (see Giustina and Veldhuis
[1]
). Sympathetic 
activity may be an important mediator of the GH response to acute exercise, possibly via 
activation of central α2-adrenergic neurons.
[1] 
Weltman et al.
[129] 
demonstrated that peak plasma 
adrenaline and nor- adrenaline concentrations preceded the peak in serum GH concentrations. 
Multiple regression analysis revealed that prior increases in noradrenaline with resulting 
significant increments in GH could not be explained by adrenaline alone.
[129]
 In creases in serum 
GH and catecholamines with exercise are also similarly affected by exercise training.
[115] 
Additionally, ghrelin, cholinergic and opioid pathways may also be involved.[1] Current 
evidence favours a modulatory effect of cholinergic pathways on the GH response to exercise 
with a less important role for opioid pathways.
[1,130] 
The role of endogenous ghrelin in the 
stimulation of GH release in response to exercise has not been elucidated, however, one study 
has measured the plasma ghrelin response to 45 minutes of aerobic exercise at lactate 
threshold.
[131] 
Plasma ghrelin levels remained unchanged from baseline throughout exercise and 
3 hours of recovery (~150 pmol/L), indicating that exercise is not associated with changes in 
plasma ghrelin. 
 
 GH Signalling and Exercise 
The regulation of energy metabolism by GH is believed to be mediated by direct interaction of 
GH with the GH receptor (GHR) on target cells.
[132] 
GHRs are found in many tissues throughout 
the body, including liver, muscle, adipose and kidney.
[133] 
Our understanding of the signal 
transduction systems that mediate GH action is limited, but it is known to involve GHR 
dimerisation, activation of Janus kinases, mitogen activated protein kinases and the signal 
transducers and activators of transcription signalling pathways.
[134] 
An excellent review of GH 
signalling and the use of trans- genic models to understand the complex biological actions of GH 
is provided by Kopchick et al.
[134] 
GH regulation during exercise at the neuroendocrine level is 
clearly multifactorial. While chronic aerobic and resistance training clearly results in different 
phenotypic responses in both men and women, the literature reviewed in this paper supports the 
view that both acute aerobic and resistance exercise produces a similar GH response (i.e. GH 
concentration peaks at or near the end of exercise with GH concentration returning to baseline by 
approximately 90 minutes postexercise). 
 
Clearly, one could argue that chronic aerobic or resistance training has divergent cumulative 
effects resulting in different phenotypic responses. However, we must consider the possibility 
that exercise-induced elevations in immunoassayable GH alone, may not be an adequate 
indicator of the role that GH plays in producing cellular changes that result in these different 
phenotypic responses. As suggested in the introduction, alternative assay techniques may be 
required to assess the importance of the changes induced by exercise. Further, several studies in 
rats have shown that sexually dimorphic differences in plasma GH profiles (i.e. males have 
intermittent GH secretion with periods of secretory quiesence, while females have continuous 
GH release), result in sexually dimorphic gene expression in the liver, that ultimately results in 
sexually dimorphic differences in whole-body growth patterns.
[135-137] 
Consequently, one must 
consider the possibility that changes in the pulsatile release patterns of GH may play an 
important role in the ability of aerobic and resistance training to induce such divergent 
phenotypic responses. Clearly, one of our greatest challenges is to link exercise-induced changes 
in GH pulsatility to downstream GH signalling changes and ultimately, changes in protein 
production. The phenotypic differences that result from chronic aerobic or resistance training 
may, in part be dependent on subtle changes in GH pulsatility that lead to diminutive, but 
important changes in the GH signalling pathway. 
 
Conclusion 
Exercise is a potent stimulus for GH release, particularly in younger men and women. However, 
the GH response to exercise appears to be reduced in older adults, as well as in those with 
obesity. The mechanisms underlying this reduction in GH have not been elucidated but may 
include primary effects on the hypothalamus and pituitary, as well as potential lifestyle or 
metabolic factors (e.g. increased visceral fat). In older adults, an exercise intervention alone is 
unlikely to restore GH secretion to levels observed in young individuals, particularly if aging has 
a primary effect on the hypothalamus that results in decreased GH secretion. Since this marked 
reduction in GH secretion is associated with unfavourable clinical profiles, interventions 
designed to reverse the effects of aging on GH secretion may result in favourable changes in risk 
factors for chronic disease. Since the administration of an oral GH secretagogue enhances GH 
secretion in older individuals at rest, it is possible that a combination of exercise and an oral GH 
secretagogue in older individuals may increase GH secretion to levels observed in young adults. 
However, the ability of this increase to produce longterm clinical benefits is unknown. 
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